Hospital Son Llatzer

At Hospital Son Llatzer in Palma, clinical research in cardiology focuses on cardiovascular disease and congenital, hereditary, and neonatal disorders, with particular attention to people at risk of developing dilated cardiomyopathy. The studies are designed to explore whether earlier treatment can help protect heart function and reduce the chance of structural changes before symptoms appear.

• Genetic carriers of dilated cardiomyopathy-causing variants
• Preventing decline in heart pumping function and ventricular enlargement
• Evaluating early therapy to delay or reduce disease expression

These trials aim to improve prevention and long-term monitoring for individuals with inherited heart risk.

Research at this site also examines symptomatic obstructive hypertrophic cardiomyopathy, a condition that can limit daily activity and cause significant heart-related symptoms. The clinical trials are comparing treatment options to better understand how to improve exercise tolerance and overall symptom control in affected adults.

• Symptomatic obstructive hypertrophic cardiomyopathy
• Improving exercise capacity and symptom management
• Comparing a newer heart therapy with standard treatment

The goal is to find approaches that may offer better functional outcomes for people living with this form of cardiomyopathy.

Clinical trial activity at Hospital Son Llatzer includes research in neoplasms, especially metastatic non-small cell lung cancer. These studies are testing whether new treatment combinations can improve outcomes for patients whose disease has spread and whose tumors show low PD-L1 expression.

• Metastatic non-small cell lung cancer
• Assessing treatment effectiveness in advanced cancer
• Exploring whether new combinations can extend survival and delay progression

This work supports the search for more effective options in advanced lung cancer care.